ASX - By Stock
|
PAA |
Re:
TOP 100 PAA SHAREHOLDERS 31/5/1924
|
|
Jakjazz
|
5 |
1.3K |
1 |
00:27 |
00:27 |
ASX - By Stock
|
5
|
1.3K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
2 |
00:11 |
00:11 |
ASX - By Stock
|
406
|
91K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
7 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
406
|
91K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
4 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
406
|
91K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
9 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
406
|
91K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Jakjazz
|
85 |
19K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
19K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
17 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
406
|
91K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
21 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
406
|
91K
|
21
|
|
ASX - By Stock
|
AZL |
Re:
Ann: World Class Lithium Research Centre to Officially Open
|
|
Jakjazz
|
34 |
8.1K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
34
|
8.1K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
406
|
91K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Jakjazz
|
85 |
19K |
16 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
19K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
10 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
406
|
91K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
406
|
91K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Jakjazz
|
85 |
19K |
12 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
19K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Jakjazz
|
85 |
19K |
33 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
19K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Jakjazz
|
85 |
19K |
21 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
19K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Jakjazz
|
85 |
19K |
22 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
19K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
8 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
406
|
91K
|
8
|
|
ASX - By Stock
|
DBI |
Re:
News: DBI Dalrymple Bay Infrastructure Posts Q1-24 Distribution Of 5.375 Au Cps
|
|
Jakjazz
|
16 |
2.9K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
16
|
2.9K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
406
|
91K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
6 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
406
|
91K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
9 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
406
|
91K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
Jakjazz
|
14 |
5.2K |
8 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
14
|
5.2K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
16 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
406
|
91K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
406
|
91K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appointment of Company Secretary
|
|
Jakjazz
|
4 |
1.6K |
10 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4
|
1.6K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
7 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
406
|
91K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
5 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
406
|
91K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Jakjazz
|
58 |
15K |
24 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
58
|
15K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
12 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
406
|
91K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
6 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
406
|
91K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
5 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
406
|
91K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Jakjazz
|
86 |
20K |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Jakjazz
|
58 |
15K |
23 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
58
|
15K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Jakjazz
|
86 |
20K |
14 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
Jakjazz
|
42 |
9.3K |
11 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
42
|
9.3K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
Jakjazz
|
42 |
9.3K |
3 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
42
|
9.3K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Jakjazz
|
406 |
91K |
18 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
406
|
91K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.4K |
357K |
4 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
357K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.4K |
357K |
10 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
357K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.4K |
357K |
10 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
357K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.4K |
357K |
14 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
357K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.4K |
357K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
357K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Jakjazz
|
86 |
20K |
18 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
86
|
20K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.4K |
357K |
9 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.4K
|
357K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
Jakjazz
|
250 |
61K |
21 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
250
|
61K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
Jakjazz
|
250 |
61K |
25 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
250
|
61K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Jakjazz
|
239 |
63K |
5 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
239
|
63K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Jakjazz
|
83 |
23K |
4 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
83
|
23K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Jakjazz
|
239 |
63K |
11 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
239
|
63K
|
11
|
|